Storia in 7 fonti

FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option

The launch of the injection faces potential threats, including the Trump administration's proposed cuts to federal funding for HIV prevention efforts.

Raccontata da

mercoledì 18 giugno 2025·usatoday.com
FDA approves new twice-yearly HIV shot. What to know
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.
mercoledì 18 giugno 2025·cnbc.com
FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option
The launch of the injection faces potential threats, including the Trump administration's proposed cuts to federal funding for HIV prevention efforts.

FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option

FDA approves new twice-yearly HIV shot. What to know

FDA approves Gilead's twice-yearly HIV prevention injection, offering a powerful and convenient new option

FDA approves long-lasting HIV-prevention drug - UPI.com

US approves Gilead’s twice-yearly shot for HIV prevention

Fda Usa approva un nuovo farmaco per prevenire l'Aids - Sanità - Ansa.it

Rivoluzione Hiv: la Fda approva le due iniezioni l’anno per prevenire l’infezione

U.S. approves twice-a-year shot to prevent HIV but cuts to public health and foreign aid cloud its prospects